middle.news
How Resonance Health’s Clinical Trials and SaMD Contracts Are Driving Growth
10:12am on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
How Resonance Health’s Clinical Trials and SaMD Contracts Are Driving Growth
10:12am on Thursday 31st of July, 2025 AEST
Key Points
Receipts from customers total $2.7M with $0.2M net positive operating cashflow
First ten patients dosed in $13.8M major pharma clinical trial on schedule
TrialsWest expands to three profitable clinical trial sites in Western Australia
SaMD division secures ~$4.5M in multi-year contracts with global pharmaceutical companies
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE